Endoanal ultrasonography-assisted percutaneous transperineal management of anorectal sepsis

Methods for preoperative assessment of anal fistula

Anal fistula is one of the most common perianal diseases, and methods for its preoperative assessment are diverse. Traditional methods include physical examination, probing, Goodsall's law, methylene blue test, and so on. Although traditional methods play a role, their accuracy for complex anal fistulas is low. Therefore, their application must be combined with other methods. Fistulography fails to depict the relationship of the fistula to the sphincter complex, and computed tomography lacks specificity to distinguish between fistula and surrounding muscle tissue. Both methods are rarely used now. Magnetic resonance imaging and three-dimensional anorectal endosonography have become routine preoperative examinations and play an important role for guiding precise surgery. However, they also have their own shortcomings. In this paper, we will summarize a variety of methods for preoperative assessment of anal fistula.

Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive-a Laboratory and Clinical Perspective

Background. Fibrin sealant became the first modern era material approved as a hemostat in the United States in 1998. It is the only agent presently approved as a hemostat, sealant, and adhesive by the Food and Drug Administration (FDA). The product is now supplied as patches in addition to the original liquid formulations. Both laboratory and clinical uses of fibrin sealant continue to grow. The new literature on this material also continues to proliferate rapidly (approximately 200 papers/year). Methods. An overview of current fibrin sealant products and their approved uses and a comprehensive PubMed based review of the recent literature (February 2012, through March 2013) on the laboratory and clinical use of fibrin sealant are provided. Product information is organized into sections based on a classification system for commercially available materials. Publications are presented in sections based on both laboratory research and clinical topics are listed in order of decreasing frequency. Results. Fibrin sealant remains useful hemostat, sealant, and adhesive. New formulations and applications continue to be developed. Conclusions. This agent remains clinically important with the recent introduction of new commercially available products. Fibrin sealant has multiple new uses that should result in further improvements in patient care.